RE: Inhibition of apoptosis signal-regulating kinase 1 might be a novel therapeutic target in the treatment of cardiorenal syndrome

被引：0
作者：
Savira, Feby [1 ,2 ]
Edgley, Amanda J. [3 ]
Jucker, Beat M. [4 ]
Willette, Robert N. [4 ]
Krum, Henry [2 ]
Kelly, Darren J. [3 ]
Kompa, Andrew R. [2 ,3 ]
Wang, Bing H. [1 ,2 ]
机构：
[1] Baker Heart & Diabet Res Inst, Biomarker Discovery Lab, Melbourne, Vic, Australia
[2] Monash Univ, Sch Publ Hlth & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic, Australia
[3] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic, Australia
[4] GlaxoSmithKline, Heart Failure Discovery Performance Unit, King Of Prussia, PA USA
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2021年 / 323卷
基金：
英国医学研究理事会;
关键词：
HYPERTROPHY; FIBROSIS;
D O I：
10.1016/j.ijcard.2020.09.021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：260 / 260
页数：1
相关论文
共 9 条
  • [1] Dickkopf-3 protects against cardiac dysfunction and ventricular remodelling following myocardial infarction
    Bao, Ming-Wei
    Cai, Zhongxiang
    Zhang, Xiao-Jing
    Li, Liangpeng
    Liu, Xiaoxiong
    Wan, Nian
    Hu, Gangying
    Wan, Fengwei
    Zhang, Rui
    Zhu, Xueyong
    Xia, Hao
    Li, Hongliang
    [J]. BASIC RESEARCH IN CARDIOLOGY, 2015, 110 (03)
  • [2] Effects of Selonsertib in Patients with Diabetic Kidney Disease
    Chertow, Glenn M.
    Pergola, Pablo E.
    Chen, Fang
    Kirby, Brian J.
    Sundy, John S.
    Patel, Uptal D.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (10): : 1980 - 1990
  • [3] Higenamine Improves Cardiac and Renal Fibrosis in Rats With Cardiorenal Syndrome via ASK1 Signaling Pathway
    Deng, Ting
    Wei, Zhenming
    Gael, Akindavyi
    Deng, Xiaofang
    Liu, Yunfeng
    Lai, Jun
    Hang, Liwei
    Yan, Quanneng
    Fu, Qiang
    Li, Zhiliang
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2020, 75 (06) : 535 - 544
  • [4] Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II - Induced cardiac hypertrophy and remodeling
    Izumiya, Y
    Kim, S
    Izumi, Y
    Yoshida, K
    Yoshiyama, M
    Matsuzawa, A
    Ichijo, H
    Iwao, H
    [J]. CIRCULATION RESEARCH, 2003, 93 (09) : 874 - 883
  • [5] ASK1 Regulates Cardiomyocyte Death but Not Hypertrophy in Transgenic Mice
    Liu, Qinghang
    Sargent, Michelle A.
    York, Allen J.
    Molkentin, Jeffery D.
    [J]. CIRCULATION RESEARCH, 2009, 105 (11) : 1110 - U140
  • [6] The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial
    Loomba, Rohit
    Lawitz, Eric
    Mantry, Parvez S.
    Jayakumar, Saumya
    Caldwell, Stephen H.
    Arnold, Hays
    Diehl, Anna Mae
    Djedjos, C. Stephen
    Han, Ling
    Myers, Robert P.
    Subramanian, G. Mani
    McHutchison, John G.
    Goodman, Zachary D.
    Afdhal, Nezam H.
    Charlton, Michael R.
    [J]. HEPATOLOGY, 2018, 67 (02) : 549 - 559
  • [7] Inhibition of apoptosis signal-regulating kinase 1 ameliorates left ventricular dysfunction by reducing hypertrophy and fibrosis in a rat model of cardiorenal syndrome
    Savira, Feby
    Wang, Bing H.
    Edgley, Amanda J.
    Jucker, Beat M.
    Willette, Robert N.
    Krum, Henry
    Kelly, Darren J.
    Kompa, Andrew R.
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 310 : 128 - 136
  • [8] Apoptosis signal-regulating kinase 1/p38 signaling pathway negatively regulates physiological hypertrophy
    Taniike, Masayuki
    Yamaguchi, Osamu
    Tsujimoto, Ikuko
    Hikoso, Shungo
    Takeda, Toshihiro
    Nakai, Atsuko
    Omiya, Shigemiki
    Mizote, Isamu
    Nakano, Yuko
    Higuchi, Yoshiharu
    Matsumura, Yasushi
    Nishida, Kazuhiko
    Ichijo, Hidenori
    Hori, Masatsugu
    Otsu, Kinya
    [J]. CIRCULATION, 2008, 117 (04) : 545 - 552
  • [9] Yang W., 2017, HEART LUNG CIRC, VS1443-9506, P31522
1